A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 Mg/24 H Versus 4.6 Mg/24 H in Severe Alzheimer's Dementia
CNS Neuroscience and Therapeutics - United Kingdom
doi 10.1111/cns.12158
Full Text
Open PDFAbstract
Available in full text
Date
August 1, 2013
Authors
Publisher
Wiley